| Ketamine administration in depressive disorders: a systematic review and meta-analysis G Fond, A Loundou, C Rabu, A Macgregor, C Lançon, M Brittner, ... Psychopharmacology 231 (18), 3663-3676, 2014 | 294 | 2014 |
| EEG neurofeedback treatments in children with ADHD: an updated meta-analysis of randomized controlled trials JA Micoulaud-Franchi, PA Geoffroy, G Fond, R Lopez, S Bioulac, P Philip Frontiers in human neuroscience 8, 906, 2014 | 165 | 2014 |
| Risk of motor vehicle accidents related to sleepiness at the wheel: a systematic review and meta-analysis S Bioulac, JAM Franchi, M Arnaud, P Sagaspe, N Moore, F Salvo, P Philip Sleep 40 (10), 2017 | 128 | 2017 |
| Consensus on the reporting and experimental design of clinical and cognitive-behavioural neurofeedback studies (CRED-nf checklist) T Ros, S Enriquez-Geppert, V Zotev, KD Young, G Wood, ... Brain 143 (6), 1674-1685, 2020 | 117 | 2020 |
| Rapid detection of generalized anxiety disorder and major depression in epilepsy: validation of the GAD-7 as a complementary tool to the NDDI-E in a French sample JA Micoulaud-Franchi, S Lagarde, G Barkate, B Dufournet, C Besancon, ... Epilepsy & Behavior 57, 211-216, 2016 | 109 | 2016 |
| Electroencephalographic neurofeedback: Level of evidence in mental and brain disorders and suggestions for good clinical practice JA Micoulaud-Franchi, A Mcgonigal, R Lopez, C Daudet, I Kotwas, ... Neurophysiologie Clinique/Clinical Neurophysiology 45 (6), 423-433, 2015 | 88 | 2015 |
| Neurofeedback: One of today's techniques in psychiatry? M Arns, JM Batail, S Bioulac, M Congedo, C Daudet, D Drapier, T Fovet, ... L'encephale 43 (2), 135-145, 2017 | 77 | 2017 |
| The bidirectional relation between emotional reactivity and sleep: From disruption to recovery. E Altena, JA Micoulaud-Franchi, PA Geoffroy, E Sanz-Arigita, S Bioulac, ... Behavioral neuroscience 130 (3), 336, 2016 | 72 | 2016 |
| Virtual human as a new diagnostic tool, a proof of concept study in the field of major depressive disorders P Philip, JA Micoulaud-Franchi, P Sagaspe, E De Sevin, J Olive, ... Scientific reports 7 (1), 1-7, 2017 | 70 | 2017 |
| Resting cortical PET metabolic changes in psychogenic non-epileptic seizures (PNES) M Arthuis, JA Micoulaud-Franchi, F Bartolomei, A McGonigal, E Guedj Journal of Neurology, Neurosurgery & Psychiatry 86 (10), 1106-1112, 2015 | 69 | 2015 |
| A preliminary study on cognitive enhancer consumption behaviors and motives of French Medicine and Pharmacology students JA Micoulaud-Franchi, A MacGregor, G Fond Eur Rev Med Pharmacol Sci 18 (13), 1875-8, 2014 | 58 | 2014 |
| One step closer to a global tool for rapid screening of major depression in epilepsy: validation of the French NDDI-E JA Micoulaud-Franchi, G Barkate, A Trébuchon-Da Fonseca, L Vaugier, ... Epilepsy & Behavior 44, 11-16, 2015 | 55 | 2015 |
| Melatonin and melatonin agonists as adjunctive treatments in bipolar disorders P Alexis Geoffroy, B Etain, JA Micoulaud Franchi, F Bellivier, P Ritter Current pharmaceutical design 21 (23), 3352-3358, 2015 | 54 | 2015 |
| (Mis) use of prescribed stimulants in the medical student community: motives and behaviors: a population-based cross-sectional study G Fond, M Gavaret, C Vidal, L Brunel, JP Riveline, JA Micoulaud-Franchi, ... Medicine 95 (16), 2016 | 53 | 2016 |
| Making psychiatric semiology great again: A semiologic, not nosologic challenge JA Micoulaud-Franchi, C Quiles, JM Batail, C Lancon, M Masson, ... L'encephale 44 (4), 343-353, 2018 | 52 | 2018 |
| Hypersomnolence, hypersomnia, and mood disorders L Barateau, R Lopez, JAM Franchi, Y Dauvilliers Current psychiatry reports 19 (2), 13, 2017 | 45 | 2017 |
| Innovative mechanisms of action for pharmaceutical cognitive enhancement: a systematic review G Fond, JA Micoulaud-Franchi, L Brunel, A Macgregor, S Miot, R Lopez, ... Psychiatry research 229 (1-2), 12-20, 2015 | 45 | 2015 |
| Reassessing “praecox feeling” in diagnostic decision making in schizophrenia: a critical review T Gozé, M Moskalewicz, MA Schwartz, J Naudin, JA Micoulaud-Franchi, ... Schizophrenia bulletin 45 (5), 966-970, 2019 | 44 | 2019 |
| D2 and D3 dopamine receptor affinity predicts effectiveness of antipsychotic drugs in obsessive-compulsive disorders: a metaregression analysis D Ducasse, L Boyer, P Michel, A Loundou, A Macgregor, ... Psychopharmacology 231 (18), 3765-3770, 2014 | 40 | 2014 |
| Parieto-temporal alpha EEG band power at baseline as a predictor of antidepressant treatment response with repetitive transcranial magnetic stimulation: a preliminary study JA Micoulaud-Franchi, R Richieri, M Cermolacce, A Loundou, C Lancon, ... Journal of affective disorders 137 (1-3), 156-160, 2012 | 40 | 2012 |
Regis LopezSleep disorders clinic, Gui de Chauliac Hospital, Montpellier FRANCEVerified email at chu-montpellier.fr
